Evidence map›Paper›PMID 32499857›Full record

ArticleThe Pan African medical journal2020

Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon.

Ngwene Hycentha Diengou, Samuel Nambile Cumber, Claude Ngwayu Nkfusai, Mbuh Salioh Mbinyui, Vecheusi Zennobia Viyoff, Fala Bede, Lilian Akwah, Joyce Mahlako Tsoka-Gwegweni, Anchang-Kimbi Judith

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ngwene Hycentha DiengouDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Samuel Nambile CumberFaculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Claude Ngwayu NkfusaiDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Mbuh Salioh MbinyuiDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Vecheusi Zennobia ViyoffDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Fala BedeHIV Free Project, Cameroon Baptist Convention Health Services, Yaounde, Cameroon.
Lilian AkwahCenter for Medical Research, Institute of Medical Research and Medicinal Plant studies, Ministry of Scientific Research and Innovation, Yaounde, Cameroon.
Joyce Mahlako Tsoka-GwegweniFaculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Anchang-Kimbi JudithDepartment of Zoology and Animal Physiology, Faculty of Science, University of Buea, Buea, Cameroon.
University of Buea · CMCameroon Baptist Convention Health Services · CMMinistry of Scientific Research and Innovation · CMUniversity of Pretoria · ZAUniversity of the Free State · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe World Health Organization (WHO) recommends that in malaria endemic areas with moderate to high transmission rates, pregnant women presenting for antenatal clinic (ANC) should receive at least three doses of intermittent preventive treatment in pregnancy (IPTp) for malaria between the 16

methodsTo reach our objectives, we carried out a cross-sectional study following informed consent with thirty-nine (39) healthcare workers (HCW) and four hundred (400) pregnant women who were either in the third trimester of pregnancy or had recently given birth in any of thirty-six (36) health facilities (HF) within the Bamenda Health District (BHD) from May to August 2014. All sites within the BHD were included. The participants were selected by simple random sampling. The principal research instrument was a structured and pre-tested questionnaire that was designed to capture socio-demographic data and data related to stage of pregnancy and knowledge about IPTp. Data was entered using Ms Excel and analysed using SPSS v20.0. Descriptive statistics (frequencies and percentages) was used to report findings. We used Chi-Square test to compare the categorical variables (Fischer's exact test was used in cases were conditions for Chi-Square test were not met).

resultsUptake for at least one dose of IPTp was 95.3% (381/400) and 54.9% (209/400) had received all three doses, 15.5% (59/400) received only one dose and 4.8% (19/400) did not receive any of the doses of IPTp. Knowledge about IPTp was associated with an increase uptake of IPTp (P<0.001). All health care providers were knowledgeable about the importance and use of IPTp. However, 35.9% reported not receiving any training on IPTp. Among the health providers, 28.2% did not know when to start IPTp and 43.59% did not know when to stop IPTp. Out of all the health care providers, 30.77% complained of medication (sulfadoxine-Pyrimethamine) stock out and 84.62% practiced the policy of direct observed therapy.

conclusionThe uptake of the third dose of IPTp is poor in the Bamenda Health District and this may be attributed to medication stock out and inadequacy of routine trainings for the health providers. The good practice observed was that of direct observed therapy by HCWs. Patient knowledge about IPTp in our study was associated with better uptake of IPTp. Encouraging education of pregnant women on the importance of IPTp, providing routine training to HCWs and promoting direct observation of therapy may improve on IPTp uptake during pregnancy.

Indexed as

Drug MonitoringMedication AdherencePatient Acceptance of Health CareAdolescentAdultCameroonCross-Sectional StudiesDirectly Observed TherapyDrug Administration ScheduleDrug CombinationsFemaleHealth FacilitiesHealth PersonnelHumansMalariaPregnancyDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineBamendafactorsintermittent preventive treatmentMalariapregnancyuptake rates

Identifiers

PMID32499857
PMCPMC7245972
OpenAlexW3008945340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.